Based on our preliminary study in PTEN conditional knock-out mice and previous studies [9], [10], we hypothesized that PLZF might be the downstream modulator cooperating with PTEN in regulating the progression of prostate cancer. The gene discussed is PTEN; the disease is prostate carcinoma.